期刊文献+

新型钙离子拮抗剂拉西地平的药理和临床作用 被引量:4

下载PDF
导出
摘要 目前,二氢砒啶拮抗剂已广泛用于高血压、冠心病等的治疗.近年来开发出的拉西地平(Lacidipine)等第二代二氢砒啶类钙离子拮抗剂,具有半衰期长、疗效高、副作用少等优点.本文就拉西地平的药理作用及临床应用作一概述.
出处 《基层医学论坛》 2003年第5期000-000,共1页 The Medical Forum
  • 相关文献

参考文献6

  • 1[1]Micheli D,Colldel Asemeraro C,et al.Lacidipine:a calcium antagonist with poten and long-lasting antihy pertersive effets in animal studies.J Cardiovasc Phanncol,1990,15:666
  • 2[2]Veglio F,Rabbia F,Molino P,et al.Analysis of 24-h blood pressure profile by Fourier series during lacidipine therapy.J Carrdiovasc phanmacol,1994,23(5):113
  • 3[3]Leonetti G,Salvi S.A long-term study comparing lacidipine and nifedipine SR in hypertinsive patients:safety data.J Cardiovasc Pharmacol,1994,23(5):108
  • 4[4]Galeone F,Giuntoli F,et al.Antihypertensive and metabolic effects of lacidipine in patients with NIDDM and /or hypertension.J Cardiovasc Phamacol,1994,23(5):105
  • 5[5]Gulizia M,Valenti R,Platania F,et al.Calcium antagonist antihypertensive treatment of non-insulin-dependent diabetics:efficacy and aafety of lacidipine SR.J Cardiovasc Pharmacol,1994,23(5):101
  • 6[6]Zampaglione B,Pascale C,Marchisio M,et al.The use of lacidipine in the management of hypertensive crises:a comparative study with nifedipine.J Cardiovasc Pharmacol,1994,23(5):116

同被引文献16

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部